Nasr, S. H., Valeri, A. M., Said, S. M., Sethi, S., Nath, K. A., Lieske, J. C., & Bu, L. (2024). Clinicopathologic Characteristics, Etiologies, and Outcome of Secondary Oxalate Nephropathy. Mayo Clinic Proceedings, 99(4), 593–606. https://doi.org/10.1016/j.mayocp.2023.08.014

Nyrén, R., Scherman, H., Axelsson, J., Chang, C. L., Olivecrona, G., & Ericsson, M. (2023). Visualizing increased uptake of [18F]FDG and [18F]FTHA in kidneys from obese high-fat diet fed C57BL/6J mice using PET/CT ex vivo. PLOS ONE, 18(2), e0281705. https://doi.org/10.1371/journal.pone.0281705

Lin, Q., Chen, O., Wise, J. P., Shi, H., Wintergerst, K. A., Cai, L., & Tan, Y. (2022). FGF1ΔHBS delays the progression of diabetic nephropathy in late-stage type 2 diabetes mouse model by alleviating renal inflammation, fibrosis, and apoptosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1868(8), 166414. https://doi.org/10.1016/j.bbadis.2022.166414

Jagannathan, G., Finkielstein, V. A., Markowitz, G. S., & Kudose, S. (2022). Armanni-Ebstein lesion in a diabetic patient with acute tubular injury. Kidney International, 102(1), 213. https://doi.org/10.1016/j.kint.2022.01.025

Winkler, T. W., Rasheed, H., Teumer, A., Gorski, M., Rowan, B. X., Stanzick, K. J., Thomas, L. F., Tin, A., Hoppmann, A., Chu, A. Y., Tayo, B., Thio, C. H. L., Cusi, D., Chai, J.-F., Sieber, K. B., Horn, K., Li, M., Scholz, M., Cocca, M., … Heid, I. M. (2022). Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals. Communications Biology, 5(1). https://doi.org/10.1038/s42003-022-03448-z